2011
DOI: 10.1038/jid.2011.181
|View full text |Cite
|
Sign up to set email alerts
|

Upregulation of Fanconi Anemia DNA Repair Genes in Melanoma Compared with Non-Melanoma Skin Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
20
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 13 publications
(16 reference statements)
1
20
0
Order By: Relevance
“…Similarly, FANC proteins including FANCM were found to be transcriptionally upregulated in melanomas [12]. Furthermore, the FANC pathway was implicated in resistance to chemotherapeutic agents [13], [14].…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, FANC proteins including FANCM were found to be transcriptionally upregulated in melanomas [12]. Furthermore, the FANC pathway was implicated in resistance to chemotherapeutic agents [13], [14].…”
Section: Discussionmentioning
confidence: 99%
“…Our results suggest that the overexpression of FANCM may give rise to chemo-resistant cells and suggest that combinatorial therapies utilizing ICL-inducing agents in conjunction with FANCM inhibitors would improve the efficacy of tumor treatment. Our results specifically address the consequences of Mph1 OE, but the up-regulation of other Fanconi genes is also associated with melanoma (88) and cellular resistance to DNA damaging agents (89,90). Thus, these therapeutic implications may also extend to other Fanconi proteins and their inhibitors.…”
Section: Discussionmentioning
confidence: 99%
“…Higher expression of FANC genes has been detected in melanoma (12) and is related to resistance to chemotherapy in other pathologies. In multiple myelomas, FANCF overexpression associates with melphalan resistance (13).…”
Section: Discussionmentioning
confidence: 99%
“…Mutation of these genes at the germinal line results in a syndrome characterized by progressive bone marrow depletion caused by apoptosis of the hematopoietic progenitors, congenital malformations, and high predisposition to malignancies, known as FA (11). On the contrary, overexpression of some of the FANC genes has been associated with melanoma (12) and the resistance to chemotherapy in multiple myeloma (13), ovarian cancer (14), and glioma (15).…”
mentioning
confidence: 99%